Creative Planning

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1540235 OVERLAND PARK, KS

Position in CRNX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$1,948,095

-$254,697 QoQ

Shares Held

53,637

+13.3% QoQ

Ownership

0.051%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 0.687957939482074.ToString("F0")% Shared 0.ToString("F0")% None 99.31204206051792.ToString("F0")%

Healthcare · as of Mar 31, 2026

Creative Planning holds $360,280,712 across 212 Biotechnology names. CRNX ranks #39 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	109,524	$48,906,846
2	REGN	Regeneron Pharmaceuticals, Inc.	40,152	$31,023,040
3	INSM	INSMED Inc	72,200	$11,806,143
4	EXEL	Exelixis, Inc.	234,142	$10,042,350
5	BBIO	BridgeBio Pharma, Inc.	119,661	$8,886,025
6	PCVX	Vaxcyte, Inc.	140,177	$8,145,685
7	ALNY	Alnylam Pharmaceuticals, Inc.	24,122	$7,981,245
8	INCY	Incyte Corp	80,874	$7,611,860

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,948,095	53,637	+13.3%	Shares	Sole	2026-05-12
2025-12-31	$2,202,792	47,321	+16.6%	Shares	Sole	2026-02-17
2025-09-30	$1,689,823	40,572	+42.5%	Shares	Defined	2025-11-14
2025-06-30	$818,768	28,469	-4.8%	Shares	Sole	2025-08-08
2025-03-31	$1,003,315	29,914	+11.5%	Shares	Sole	2025-05-15
2024-12-31	$1,372,124	26,836	+35.5%	Shares	Defined	2025-02-14
2024-09-30	$1,012,188	19,808	+52.4%	Shares	Defined	2024-10-11
2024-06-30	$582,133	12,997	+20.6%	Shares	Sole	2024-08-15
2024-03-31	$504,283	10,773	—	Shares	Defined	2024-05-13
No filing history on record for this holder in this stock.